BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 23205908)

  • 1. Synovial sarcoma of the lung in a patient who received radioactive iodine therapy for thyroid cancer.
    Vora A; Schneider AB
    Thyroid; 2013 Mar; 23(3):371-5. PubMed ID: 23205908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary gland malignancy and radioiodine therapy for thyroid cancer.
    Klubo-Gwiezdzinska J; Van Nostrand D; Burman KD; Vasko V; Chia S; Deng T; Kulkarni K; Wartofsky L
    Thyroid; 2010 Jun; 20(6):647-51. PubMed ID: 20470209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of lung carcinoma induced by radioactive iodine given for disseminated thyroid carcinoma.
    Laing RW; Saunders MI
    Clin Oncol (R Coll Radiol); 1992 Nov; 4(6):394-5. PubMed ID: 1463693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma.
    Kim HJ; Kim NK; Choi JH; Kim SW; Jin SM; Suh S; Bae JC; Min YK; Chung JH; Kim SW
    Clin Endocrinol (Oxf); 2013 Apr; 78(4):614-20. PubMed ID: 22957654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study.
    Teng CJ; Hu YW; Chen SC; Yeh CM; Chiang HL; Chen TJ; Liu CJ
    J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26538627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy outcome after diagnosis of differentiated thyroid carcinoma: no deleterious effect after radioactive iodine treatment.
    Chow SM; Yau S; Lee SH; Leung WM; Law SC
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):992-1000. PubMed ID: 15234032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Four cases of hematologic malignancy following radioactive iodine therapy for thyroid cancer].
    Im M; Lee JK; Hong YJ; Hong SI; Kang HJ; Na II; Ryoo BY; Cheon GJ; Lee HN; Chang YH
    Korean J Lab Med; 2008 Dec; 28(6):425-9. PubMed ID: 19127106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy.
    Vassilopoulou-Sellin R; Schultz PN; Haynie TP
    Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current controversies in the initial post-surgical radioactive iodine therapy for thyroid cancer: a narrative review.
    Blumhardt R; Wolin EA; Phillips WT; Salman UA; Walker RC; Stack BC; Metter D
    Endocr Relat Cancer; 2014; 21(6):R473-84. PubMed ID: 25277792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes following empiric radioiodine therapy in patients with structurally identifiable metastatic follicular cell-derived thyroid carcinoma with negative diagnostic but positive post-therapy 131I whole-body scans.
    Sabra MM; Grewal RK; Tala H; Larson SM; Tuttle RM
    Thyroid; 2012 Sep; 22(9):877-83. PubMed ID: 22827641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe hyponatremia following radioactive iodine therapy in patients with differentiated thyroid cancer.
    Kim SK; Yun GY; Kim KH; Park SK; Choi HY; Ha SK; Park HC
    Thyroid; 2014 Apr; 24(4):773-7. PubMed ID: 24093878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis.
    Sawka AM; Thabane L; Parlea L; Ibrahim-Zada I; Tsang RW; Brierley JD; Straus S; Ezzat S; Goldstein DP
    Thyroid; 2009 May; 19(5):451-7. PubMed ID: 19281429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetry-guided radioactive iodine treatment in patients with metastatic differentiated thyroid cancer: largest safe dose using a risk-adapted approach.
    Dorn R; Kopp J; Vogt H; Heidenreich P; Carroll RG; Gulec SA
    J Nucl Med; 2003 Mar; 44(3):451-6. PubMed ID: 12621014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary pulmonary synovial sarcoma: a case report with unique and impressive computed tomography findings.
    Kambo JS; Richardson B; Ionescu DN; Tucker T; Kraushaar G
    Can Respir J; 2015; 22(1):e1-3. PubMed ID: 25664459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild decreases in white blood cell and platelet counts are present one year after radioactive iodine remnant ablation.
    Molinaro E; Leboeuf R; Shue B; Martorella AJ; Fleisher M; Larson S; Tuttle RM
    Thyroid; 2009 Oct; 19(10):1035-41. PubMed ID: 19772430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioactive Iodine-Related Clonal Hematopoiesis in Thyroid Cancer Is Common and Associated With Decreased Survival.
    Boucai L; Falcone J; Ukena J; Coombs CC; Zehir A; Ptashkin R; Berger MF; Levine RL; Fagin JA
    J Clin Endocrinol Metab; 2018 Nov; 103(11):4216-4223. PubMed ID: 30137527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer.
    Tuttle RM; Leboeuf R; Robbins RJ; Qualey R; Pentlow K; Larson SM; Chan CY
    J Nucl Med; 2006 Oct; 47(10):1587-91. PubMed ID: 17015892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twenty-five years after Chernobyl: outcome of radioiodine treatment in children and adolescents with very high-risk radiation-induced differentiated thyroid carcinoma.
    Reiners C; Biko J; Haenscheid H; Hebestreit H; Kirinjuk S; Baranowski O; Marlowe RJ; Demidchik E; Drozd V; Demidchik Y
    J Clin Endocrinol Metab; 2013 Jul; 98(7):3039-48. PubMed ID: 23616148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary morbidity and quality of life following radioactive iodine for well-differentiated thyroid cancer.
    Dingle IF; Mishoe AE; Nguyen SA; Overton LJ; Gillespie MB
    Otolaryngol Head Neck Surg; 2013 May; 148(5):746-52. PubMed ID: 23462656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary synovial sarcoma presenting as a pneumothorax during pregnancy.
    Esaka EJ; Celebrezze JU; Golde SH; Chiossi G; Thomas RL
    Obstet Gynecol; 2008 Feb; 111(2 Pt 2):555-8. PubMed ID: 18239021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.